Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases

Arthritis Care and Research

Volumn 66, Issue 1, 2014, Pages 104-112

  Mavrogeni, Sophie ^a   Sfikakis, Petros P ^b   Gialafos, Elias ^c   Bratis, Konstantinos ^a   Karabela, Georgia ^d   Stavropoulos, Efthymios ^d   Spiliotis, Georgios ^d   Sfendouraki, Eliza ^c   Panopoulos, Stylianos ^b   Bournia, Vasiliki ^b   Kolovou, Genovefa ^a   Kitas, George D ^e  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c BIOIATRIKI HEALTHCARE GROUP   (Greece)

^d ATHENS NAVAL HOSPITAL   (Greece)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GADOLINIUM PENTETATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STEROID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CHURG STRAUSS SYNDROME; CONNECTIVE TISSUE DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART EDEMA; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HUMAN; HUMAN TISSUE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MYOCARDITIS; MYOSITIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PERICARDITIS; PLEUROPERICARDITIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SARCOIDOSIS; STRESS ECHOCARDIOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; CARDIOVASCULAR SYSTEM; CONNECTIVE TISSUE DISEASES; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; GADOLINIUM; HUMANS; INCIDENCE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDITIS; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULITIS;

EID: 84891096394     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22181     Document Type: Article

References (48)

1. Knockaert DC,. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007; 28: 1797-804.
2. Gonzalez-Gay MA, Garcia-Porrua C,. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27: 729-49.
3. Jayne D,. The diagnosis of vasculitis. Best Pract Res Clin Rheumatol 2009; 23: 445-53.
4. Pipitone N, Versari A, Salvarani C,. Role of imaging studies in the diagnosis and followup of large-vessel vasculitis: an update. Rheumatology (Oxford) 2008; 47: 403-8.
5. Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, et al. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum 2009; 61: 1121-9.
6. Luqmani RA, Pathare S, Kwok-Fai TL,. How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol 2005; 19: 321-36.
7. Mavrogeni S, Vassilopoulos D,. Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases? Semin Arthritis Rheum 2011; 41: 488-96.
8. Mavrogeni S, Spargias K, Markussis V, Kolovou G, Demerouti E, Papadopoulou E, et al. Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm Allergy Drug Targets 2009; 8: 390-7.
9. Raman SV, Aneja A, Jarjour WN,. CMR in inflammatory vasculitis. J Cardiovasc Magn Reson 2012; 14: 82.
10. Bellenger NG, Pennell DJ,. Ventricular function. In:, Manning WJ, Pennell DJ, editors. Cardiovascular magnetic resonance. New York: Churchill Livingstone; 2002. p. 99-111.
11. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90: 29-34.
12. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ,. Interstudy reproducibility of right ventricular volumes, function and mass with cardiovascular magnetic resonance. Am Heart J 2004; 147: 218-23.
13. Maceira AM, Prasad SK, Khan M, Pennell DJ,. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006; 8: 417-26.
14. Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005; 45: 1815-22.
15. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
16. Robbers LF, Baars EN, Brouwer WP, Beek AM, Hofman MB, Niessen HW, et al. T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions. Circ Cardiovasc Imaging 2012; 5: 423-6.
17. Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012; 60: 408-20.
18. Eitel I, Friedrich MG,. T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson 2011; 13: 13.
19. Cury RC, Shash K, Nagurney JT, Rosito G, Shapiro MD, Nomura CH, et al. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation 2008; 118: 837-44.
20. Underwood R, Bax JJ, von Dahl J, Henein MY, Van Rossum AC, Schwartz E, et al. Imaging techniques for the assessment of myocardial hibernation: report of a study group of the European Society of Cardiology. Eur Heart J 2004; 25: 815-36.
21. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-53.
22. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006; 113: 2733-43.
23. Shigemitsu H, Nagai S, Sharma OP,. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med 2007; 13: 434-8.
24. Piette JC, Chapelon C, Boussen K, Mouthon JM, Guillevin L, Bletry O, et al. Lupus vasculitis. Ann Med Interne (Paris) 1987; 138: 425-36. In French.
25. Sung JM, Hsu SC, Chen FF, Huang JJ,. Systemic lupus erythematosus presented as non-inflammatory necrotizing vasculopathy-induced ischemic glomerulopathy and small vessels-related ischemic cardiomyopathy. Lupus 2002; 11: 458-62.
26. Abu-Shakra M, Koh ET, Treger T, Lee P,. Pericardial effusion and vasculitis in a patient with systemic sclerosis. J Rheumatol 1995; 22: 1386-8.
27. Mavrogeni S, Bratis K, Sfikakis PP,. Pleuro-pericarditis, vasculitis, subendocardial and nodular biventricular fibrosis: the multiple faces of systemic sclerosis detected by cardiac magnetic resonance in the same patient. Int J Cardiol 2013; 163: e26-7.
28. Bely M, Apathy A,. Vasculitis in rheumatoid arthritis. Orv Hetil 1996; 137: 1571-8. In Hungarian.
29. Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 2009; 88: 236-43.
30. Watanabe E, Kimura F, Nakajima T, Hiroe M, Kasai Y, Nagata M, et al. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function. J Thorac Imaging 2013; 28: 60-6.
31. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al, and the American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, and Heart Rhythm Society. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-235.
32. Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 51-60.
33. O'Neill SG, Woldman S, Bailliard F, Norman W, McEwan J, Isenberg DA, et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis 2009; 68: 1478-81.
34. Mavrogeni S, Bratis K, Kolovou G,. Pathophysiology of Q waves in II, III, avF in systemic lupus erythematosus: evaluation using cardiovascular magnetic resonance imaging. Lupus 2012; 21: 821-9.
35. Abdel-Aty H, Siegle N, Natusch A, Gromnica-Ihle E, Wassmuth R, Dietz R, et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 2008; 17: 561-7.
36. Mavrogeni S, Bratis K, Markussis V, Spargias C, Papadopoulou E, Papamentzelopoulos S, et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus: differentiation from viral myocarditis. Lupus 2013; 22: 34-43.
37. Mavrogeni S, Bratis K, van Wijk K, Stavropoulos E, Hautemann D, Reiber JH, et al. Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance. Int J Cardiol 2012; 159: e56-8.
38. Pappas DA, Taube JM, Bathon JM, Giles JT,. A 73-year-old woman with rheumatoid arthritis and shortness of breath. Arthritis Rheum 2008; 59: 892-9.
39. Ahern M, Lever JV, Cosh J,. Complete heart block in rheumatoid arthritis. Ann Rheum Dis 1983; 42: 389-97.
40. Chung JW, Joe DY, Park HJ, Kim HA, Park HS, Suh CH,. Clinical characteristics of lupus myocarditis in Korea. Rheumatol Int 2008; 28: 275-80.
41. Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD,. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 2002; 1: 338-47.
42. Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, et al. Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum 2010; 62: 627-34.
43. Mavrogeni S, Bratis K, Karabela G, Stavropoulos E, Sfendouraki E, Kolovou G,. Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging. Int J Cardiol 2013; 164: e3-4.
44. Mavrogeni S, Douskou M, Manoussakis MN,. Contrast-enhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations [letter]. JACC Cardiovasc Imaging 2011; 4: 1324-5.
45. Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther 2010; 12: R171.
46. Schalla S, Nagel E, Lehmkuhl H, Klein C, Bornstedt A, Schnackenburg B, et al. Comparison of magnetic resonance real-time imaging of LV function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol 2001; 87: 95-9.
47. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al, and the International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009; 53: 1475-87.
48. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013; 309: 896-908.